Last reviewed · How we verify

Inahled Isoflurane — Competitive Intelligence Brief

Inahled Isoflurane (Inahled Isoflurane) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Volatile anesthetic. Area: Anesthesiology.

phase 3 Volatile anesthetic GABA-A receptor, NMDA receptor Anesthesiology Small molecule Live · refreshed every 30 min

Target snapshot

Inahled Isoflurane (Inahled Isoflurane) — Assistance Publique - Hôpitaux de Paris. Inhaled isoflurane is a volatile anesthetic that enhances inhibitory neurotransmission and suppresses excitatory signaling in the central nervous system to produce anesthesia.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Inahled Isoflurane TARGET Inahled Isoflurane Assistance Publique - Hôpitaux de Paris phase 3 Volatile anesthetic GABA-A receptor, NMDA receptor
sevoflurane in step up concentration sevoflurane in step up concentration University Hospital, Ghent marketed Volatile general anesthetic GABA-A receptor, NMDA receptor
Sevoflurane/Ultane Sevoflurane/Ultane Kaohsiung Medical University Chung-Ho Memorial Hospital marketed Volatile general anesthetic GABA-A receptor, NMDA receptor
Isoflurane, Sevoflurane or Desflurane Isoflurane, Sevoflurane or Desflurane King's College Hospital NHS Trust marketed Volatile anesthetic GABA-A receptor, NMDA receptor
Suprane (desflurane), Baxter Suprane (desflurane), Baxter Medical University of Gdansk marketed Volatile anesthetic GABA-A receptor, NMDA receptor
Sevoflurane Inhalation Liquid Sevoflurane Inhalation Liquid Damanhour Teaching Hospital marketed Volatile general anesthetic GABA-A receptor, NMDA receptor
Isoflurane Volatile Liquid Isoflurane Volatile Liquid Federal University of São Paulo marketed Volatile anesthetic GABA-A receptor, NMDA receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Volatile anesthetic class)

  1. Medical University of Gdansk · 2 drugs in this class
  2. Assistance Publique - Hôpitaux de Paris · 1 drug in this class
  3. Federal University of São Paulo · 1 drug in this class
  4. King's College Hospital NHS Trust · 1 drug in this class
  5. London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · 1 drug in this class
  6. The Cleveland Clinic · 1 drug in this class
  7. University Hospital, Basel, Switzerland · 1 drug in this class
  8. Asan Medical Center · 1 drug in this class
  9. University Hospital, Clermont-Ferrand · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Inahled Isoflurane — Competitive Intelligence Brief. https://druglandscape.com/ci/inahled-isoflurane. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: